CU Anschutz
Anschutz Health Sciences Building
1890 N Revere Ct
Suite 6202
Aurora, CO 80045
Neurexis Therapeutics, Inc. to Develop a New Medication for the Prevention of Brain Damage Following Ischemic Events Such as Stroke
Default sub title
minute read
by VIC Technology Venture Development | April 22, 2020
